by Thomas Hanselmann This blog post reviews a must-read paper for anyone involved in next-generation sequencing (NGS) – “Short Barcodes for Next Generation Sequencing” by Mir et al. (2013) –
In vitro tools that support medical diagnosis and treatment decisions are highly complex. In addition to increased scientific and engineering complexity, in vitro diagnostic tools undergo a lengthy regulatory approval process that includes complex factors during development and market launch, and also throughout the entire product life cycle. We have many years of experience in successfully developing, launching, and maintaining cutting-edge diagnostics for regulatory markets around the globe.